Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study
Templeton A, Schlegel M, Fleisch F, Rettenmund G, Schöbi B, Henz S, Eich G. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study. Infection 2008; 36:322-7.
01.08.2008Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study
01.08.2008Infection 2008; 36:322-7
Templeton Arnoud, Schlegel Matthias, Fleisch F, Rettenmund G, Schöbi B, Henz Samuel, Eich G
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer
Früh M, Spiro S, Douillard J, Scagliotti G, Le Chevalier T, Winton T, Tribodet H, Ding K, Seymour L, Pignon J, Rolland E, Shepherd F. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3573-81.
20.07.2008Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer
20.07.2008Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3573-81
Früh Martin, Spiro Stephen, Douillard Jean Yves, Scagliotti Giorgio V, Le Chevalier Thierry, Winton Timothy, Tribodet Hélène, Ding Keyue, Seymour Lesley, Pignon Jean-Pierre, Rolland Estelle, Shepherd Frances A
Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
Kraus M, Hartmann J, Koscielniak E, Ovaa H, Overkleeft H, Rückrich T, Müller H, Gogel J, Malenke E, Driessen C. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis. Molecular cancer therapeutics 2008; 7:1940-8.
01.07.2008Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
01.07.2008Molecular cancer therapeutics 2008; 7:1940-8
Kraus Marianne, Hartmann Jörg Thomas, Koscielniak Ewa, Ovaa Huib, Overkleeft Herman, Rückrich Thomas, Müller Holger, Gogel Jeannette, Malenke Elke, Driessen Christoph
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
von Moos R, Caspar C, Thürlimann B, Angst R, Inauen R, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M. Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study. Ann Oncol 2008; 19:1266-70.
01.07.2008Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
01.07.2008Ann Oncol 2008; 19:1266-70
von Moos R, Caspar C B, Thürlimann Beat, Angst Rahel, Inauen Roman, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Regan M, SOFT/TEXT/PERCHE Steering Committee, Gelber R, Goldhirsch A, Coates A, Castiglione-Gertsch M, Maibach R, Thürlimann B, Price K, Fleming G, Francis P, Perez E, Torrisi R, Walley B, Pagani O, International Breast Cancer Study Group. Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?. Ann Oncol 2008; 19:1231-41.
01.07.2008Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
01.07.2008Ann Oncol 2008; 19:1231-41
Regan M M, SOFT/TEXT/PERCHE Steering Committee, Gelber R D, Goldhirsch A, Coates A S, Castiglione-Gertsch M, Maibach R, Thürlimann Beat, Price K N, Fleming G F, Francis P, Perez E A, Torrisi R, Walley B, Pagani O, International Breast Cancer Study Group
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
Pestalozzi B, Goldhirsch A, Coates A, Castiglione-Gertsch M, Viale G, Murray E, Thürlimann B, Snyder R, Lindtner J, Holmberg S, Gelber R, Price K, Gusterson B, Mallon E, Zahrieh D, International Breast Cancer Study Group. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. JCO 2008; 26:3006-14.
20.06.2008Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
20.06.2008JCO 2008; 26:3006-14
Pestalozzi Bernhard C, Goldhirsch Aron, Coates Alan S, Castiglione-Gertsch Monica, Viale Giuseppe, Murray Elizabeth, Thürlimann Beat, Snyder Raymond, Lindtner Jurij, Holmberg Stig B, Gelber Richard D, Price Karen N, Gusterson Barry A, Mallon Elizabeth, Zahrieh David, International Breast Cancer Study Group
[Follow-up recommendations for patients after curative treatment of invasive breast cancer]
Zuber M, Viehl C, Gueller U, Langer I. [Follow-up recommendations for patients after curative treatment of invasive breast cancer]. Ther Umsch 2008; 65:319-21.
01.06.2008[Follow-up recommendations for patients after curative treatment of invasive breast cancer]
01.06.2008Ther Umsch 2008; 65:319-21
Zuber Markus, Viehl Carsten T, Gueller Ulrich, Langer Igor
Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
Rosenthal R, Viehl C, Gueller U, Weber W, Adamina M, Spagnoli G, Heberer M, Zuber M. Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal. J Am Coll Surg 2008; 207:95-105.
23.05.2008Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
23.05.2008J Am Coll Surg 2008; 207:95-105
Rosenthal Rachel, Viehl Carsten T, Gueller Ulrich, Weber Walter P, Adamina Michel, Spagnoli Giulio C, Heberer Michael, Zuber Markus
Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.
Horger M, Pereira P, Claussen C, Kanz L, Vonthein R, Denecke B, Driessen C. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol 2008; 81:386-96.
01.05.2008Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.
01.05.2008Br J Radiol 2008; 81:386-96
Horger Marius, Pereira Philippe, Claussen Claus Detlef, Kanz Lothar, Vonthein Reinhard, Denecke Barbara, Driessen Christoph
Caveats in the interpretation of the surgical literature
Gueller U. Caveats in the interpretation of the surgical literature. Br J Surg 2008; 95:541-6.
01.05.2008Caveats in the interpretation of the surgical literature
01.05.2008Br J Surg 2008; 95:541-6
Gueller Ulrich
Anti-nicotine abuse vaccines in the pipeline: an update
Cerny T. Anti-nicotine abuse vaccines in the pipeline: an update. Expert opinion on investigational drugs 2008; 17:691-6.
01.05.2008Anti-nicotine abuse vaccines in the pipeline: an update
01.05.2008Expert opinion on investigational drugs 2008; 17:691-6
Cerny Thomas
Dose-Dense Therapy
Untch M, Bergh J, Citron M, Hudis C, Huober J, Möbus V, Steger G. Dose-Dense Therapy. Breast Care (Basel) 2008; 3:134-138.
28.04.2008Dose-Dense Therapy
28.04.2008Breast Care (Basel) 2008; 3:134-138
Untch Michael, Bergh Jonas, Citron Mark, Hudis Clifford A, Huober Jens, Möbus Volker, Steger Günter
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
Crivellari D, Chirgwin J, Smith I, Rabaglio M, Gladieff L, Del Mastro L, Láng I, Colleoni M, Gelber R, Castiglione-Gertsch M, Paridaens R, Forbes J, Mauriac L, Mouridsen H, Thürlimann B, Price K, Coates A, Sun Z, Goldhirsch A. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. JCO 2008; 26:1972-9.
20.04.2008Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
20.04.2008JCO 2008; 26:1972-9
Crivellari Diana, Chirgwin Jacquie H, Smith Ian E, Rabaglio Manuela, Gladieff Laurence, Del Mastro Lucia, Láng István, Colleoni Marco, Gelber Richard D, Castiglione-Gertsch Monica, Paridaens Robert J, Forbes John F, Mauriac Louis, Mouridsen Henning, Thürlimann Beat, Price Karen N, Coates Alan S, Sun Zhuoxin, Goldhirsch Aron
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
von Minckwitz G, Kaufmann M, Mehta K, Loibl S, Jackisch C, Costa S, Huober J, Gerber B, Hilfrich J, Eidtmann H, Hanusch C, Vogel P, Kümmel S, German Breast Group. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. Journal of the National Cancer Institute 2008; 100:542-51.
16.04.2008Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
16.04.2008Journal of the National Cancer Institute 2008; 100:542-51
von Minckwitz Gunter, Kaufmann Manfred, Mehta Keyur, Loibl Sibylle, Jackisch Christian, Costa Serban Dan, Huober Jens, Gerber Bernd, Hilfrich Jörn, Eidtmann Holger, Hanusch Claus, Vogel Petra, Kümmel Sherko, German Breast Group
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
von Minckwitz G, Kaufmann M, Mehta K, Loibl S, Jackisch C, Costa S, Huober J, Gerber B, Hilfrich J, Eidtmann H, Hanusch C, Vogel P, Kümmel S, German Breast Group. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. Journal of the National Cancer Institute 2008; 100:552-62.
16.04.2008Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
16.04.2008Journal of the National Cancer Institute 2008; 100:552-62
von Minckwitz Gunter, Kaufmann Manfred, Mehta Keyur, Loibl Sibylle, Jackisch Christian, Costa Serban Dan, Huober Jens, Gerber Bernd, Hilfrich Jörn, Eidtmann Holger, Hanusch Claus, Vogel Petra, Kümmel Sherko, German Breast Group
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
Köberle D, Rust C, Bieri G, Neuweiler J, Terraciano L, Ruhstaller T, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer 2008; 98:1204-9.
08.04.2008Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
08.04.2008British journal of cancer 2008; 98:1204-9
Köberle Dieter, Rust C, Bieri G, Neuweiler Jörg, Terraciano L, Ruhstaller Thomas, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M
Extraneural spread of glioblastoma--report of two cases
Templeton A, Hofer S, Toepfer M, Sommacal A, Fretz C, Cerny T, Gillessen Sommer S. Extraneural spread of glioblastoma--report of two cases. Onkologie 2008; 31:192-4.
01.04.2008Extraneural spread of glioblastoma--report of two cases
01.04.2008Onkologie 2008; 31:192-4
Templeton Arnoud, Hofer Silvia, Toepfer Michael, Sommacal Andreas, Fretz Christian, Cerny Thomas, Gillessen Sommer Silke
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
Templeton A, Brändle M, Cerny T, Gillessen Sommer S. Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5.
01.04.2008Remission of diabetes while on sunitinib treatment for renal cell carcinoma
01.04.2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5
Templeton Arnoud, Brändle Michael, Cerny Thomas, Gillessen Sommer Silke
[New treatment approaches in breast cancer]
Spirig C, Thürlimann B, Huober J. [New treatment approaches in breast cancer]. Therapeutische Umschau. Revue thérapeutique 2008; 65:207-10.
01.04.2008[New treatment approaches in breast cancer]
01.04.2008Therapeutische Umschau. Revue thérapeutique 2008; 65:207-10
Spirig Christian, Thürlimann Beat, Huober Jens
[Adjuvant endocrine therapy in breast cancer]
Huober J, Thürlimann B. [Adjuvant endocrine therapy in breast cancer]. Therapeutische Umschau. Revue thérapeutique 2008; 65:193-200.
01.04.2008[Adjuvant endocrine therapy in breast cancer]
01.04.2008Therapeutische Umschau. Revue thérapeutique 2008; 65:193-200
Huober Jens, Thürlimann Beat